The UK Health Security Agency (UKHSA) has provided a significant update on the ongoing meningitis outbreak in Kent. According to the UKHSA, there have been no new cases of meningitis reported in the past 24 hours. However, investigations are still underway regarding the outbreak of meningococcal disease in Kent.
As of 12:30 pm on March 22, there have been 20 confirmed laboratory cases and 9 notifications that are currently under investigation, totaling 29 cases. This update follows the unfortunate deaths of two individuals earlier this month, which were linked to an outbreak associated with Club Chemistry nightclub in Canterbury.
Dr. Sherine Thomas, an Infectious Diseases Consultant at UKHSA, emphasized the agency’s continued vigilance in monitoring for new cases and collaborating closely with NHS England and local authorities nationwide to promptly respond to any identified cases. Dr. Thomas also expressed gratitude for the proactive response from eligible individuals in seeking antibiotics and vaccination.
While the risk to the general population remains low, it is crucial for people to be aware of the symptoms of invasive meningococcal disease and seek immediate medical attention if they or someone they know exhibit these symptoms. The UKHSA is working in conjunction with partners to identify contacts and provide necessary treatment.
The number of suspected cases under investigation has decreased from 11 to nine, resulting in a total of 29 cases, down from 34 previously. Nineteen out of the 20 confirmed cases are attributed to meningitis B, all of which have required hospitalization.
One of the suspected cases has been linked to a second academic institution in Kent, in addition to the University of Kent. The East Kent Colleges (EKC) Group informed parents and carers about a college student being treated for a suspected case of meningitis. Despite a decrease in the number of individuals queuing up for the menB vaccine or antibiotics since the rollout began, the UKHSA anticipates further downgrading of cases in the coming days as additional laboratory assessments are completed.
Tragically, two students, including 18-year-old Juliette, have succumbed to the infection. Juliette, described as “fit, healthy, and strong” by her family, displayed initial symptoms of vomiting and cheek discoloration before her sudden deterioration. Despite receiving immediate medical attention, she tragically lost her battle with meningitis within hours.
Vinny Smith, the chief executive of Meningitis Research Foundation, previously advocated for the routine availability of the menB vaccination for at-risk age groups on the NHS, a call that was not implemented due to cost-effectiveness concerns.